WallStreetZen

NASDAQ: AMGN
Amgen Inc Stock Forecast, Predictions & Price Target

Analyst price target for AMGN

Based on 16 analysts offering 12 month price targets for Amgen Inc.
Min Forecast
$215.00-13.64%
Avg Forecast
$260.56+4.66%
Max Forecast
$300.00+20.51%

Should I buy or sell AMGN stock?

Buy
Strong Buy
6 analysts 35.29%
Buy
4 analysts 23.53%
Hold
7 analysts 41.18%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AMGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Matthew Harrison
Morgan Stanley
Strong BuyMaintains$279.00+12.07%2021-03-05
Alethia Young
Cantor Fitzgerald
Strong BuyMaintains$295.00+18.50%2021-02-03
Christopher Raymond
Piper Sandler
Strong BuyMaintains$260.00+4.44%2021-02-03
Anonymous
Morgan Stanley
Strong BuyMaintains$285.00+14.48%2021-01-19
Michael Yee
Jefferies
Strong BuyMaintains$300.00+20.51%2020-07-29
Geoff Meacham
Bank of America
Strong BuyReiterates$265.00+6.45%2020-05-01
Jay Olson
Oppenheimer
BuyMaintains$275.00+10.46%2021-04-05
Evan Seigerman
Credit Suisse
BuyMaintains$265.00+6.45%2021-02-03
Dane Leone
Raymond James
BuyUpgrades$255.00+2.43%2020-10-26
Kevin Huang
CFRA
BuyMaintains$259.00+4.04%2020-05-01

1 of 2

Forecast return on equity

Is AMGN forecast to generate an efficient return?
Company
126.08%
Industry
76.5%
Market
32,369.88%
AMGN's Return on Equity is forecast to be high in 3 years (126.08%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AMGN forecast to generate an efficient return on assets?
Company
18.85%
Industry
16.91%
Market
11,660.33%
AMGN is forecast to generate higher Return on Assets (18.85%) than the US Drug Manufacturers - General industry average (16.91%)
Forecast

AMGN earnings per share forecast

What is AMGN's earnings per share in the next 3 years based on estimates from 14 analysts?
Avg 1 year Forecast
$16.74+34.99%
Avg 2 year Forecast
$18.22+46.96%
Avg 3 year Forecast
$19.39+56.39%
AMGN's earnings are forecast to grow at a rate of 16.22% per year, which is not exceptional
Forecast

AMGN revenue forecast

What is AMGN's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$26.4B+3.72%
Avg 2 year Forecast
$27.4B+7.87%
Avg 3 year Forecast
$28.2B+10.95%
AMGN's revenue is forecast to grow at a rate of 3.53% per year, which is not exceptional
Forecast

AMGN earnings growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
16.22%
Industry
33.91%
Market
23.13%
AMGN's earnings are forecast to grow slower (16.22% per year) than the US Drug Manufacturers - General industry average (33.91%)
Forecast
AMGN's earnings are forecast to grow slower (16.22% per year) than the US market average (23.13%)
Forecast
AMGN's earnings are forecast to grow faster (16.22% per year) than the risk-free savings rate (1.7%)
Forecast

AMGN revenue growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.53%
Industry
5.95%
Market
15.05%
AMGN's revenues are forecast to grow slower (3.53% per year) than the US Drug Manufacturers - General industry average (5.95%)
Forecast
AMGN's revenues are forecast to grow slower (3.53% per year) than the US market average (15.05%)
Forecast

Amgen Stock Forecast FAQ

Is Amgen Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 17 Wall Street analysts covering (NASDAQ: AMGN) stock is to Buy AMGN stock.

Out of 17 analysts, 6 (35.29%) are recommending AMGN as a Strong Buy, 4 (23.53%) are recommending AMGN as a Buy, 7 (41.18%) are recommending AMGN as a Hold, 0 (0%) are recommending AMGN as a Sell, and 0 (0%) are recommending AMGN as a Strong Sell.

What is AMGN's earnings growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual earnings growth rate of 16.22% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 33.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.13%.

Amgen's earnings in 2021 is $7,264,000,000.On average, 14 Wall Street analysts forecast AMGN's earnings for 2021 to be $9,744,687,529, with the lowest AMGN earnings forecast at $9,460,239,945, and the highest AMGN earnings forecast at $9,937,618,207. On average, 12 Wall Street analysts forecast AMGN's earnings for 2022 to be $10,608,567,532, with the lowest AMGN earnings forecast at $9,955,083,265, and the highest AMGN earnings forecast at $12,190,610,735.

In 2023, AMGN is forecast to generate $11,289,704,808 in earnings, with the lowest earnings forecast at $10,391,709,724 and the highest earnings forecast at $12,161,502,305.

What is AMGN's revenue growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 3.53% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.05%.

Amgen's revenue in 2021 is $25,424,000,000.On average, 7 Wall Street analysts forecast AMGN's revenue for 2021 to be $15,351,889,342,284, with the lowest AMGN revenue forecast at $15,211,483,662,948, and the highest AMGN revenue forecast at $15,451,820,331,040. On average, 10 Wall Street analysts forecast AMGN's revenue for 2022 to be $15,966,595,940,178, with the lowest AMGN revenue forecast at $15,243,502,936,608, and the highest AMGN revenue forecast at $16,574,515,034,224.

In 2023, AMGN is forecast to generate $16,422,371,089,164 in revenue, with the lowest revenue forecast at $15,801,220,466,904 and the highest revenue forecast at $16,850,684,180,384.

What is AMGN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AMGN) forecast ROA is 18.85%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.91%.

What is AMGN's Price Target?

According to 16 Wall Street analysts that have issued a 1 year AMGN price target, the average AMGN price target is $260.56, with the highest AMGN stock price forecast at $300.00 and the lowest AMGN stock price forecast at $215.00.

On average, Wall Street analysts predict that Amgen's share price could stay at $260.56 by Apr 5, 2022. The average Amgen stock price prediction forecasts a potential downside of N/A from the current AMGN share price of $248.95.

What is AMGN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's current Earnings Per Share (EPS) is $12.40. On average, analysts forecast that AMGN's EPS will be $16.74 for 2021, with the lowest EPS forecast at $16.25, and the highest EPS forecast at $17.07. On average, analysts forecast that AMGN's EPS will be $18.22 for 2022, with the lowest EPS forecast at $17.10, and the highest EPS forecast at $20.94. In 2023, AMGN's EPS is forecast to hit $19.39 (min: $17.85, max: $20.89).

What is AMGN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AMGN) forecast ROE is 126.08%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.